Repligen Corporation

Repligen Corporation

  • 41 Seyon St Ste 100 Bldg 1
  • Waltham, Massachusetts
  • 2453
  • Phone: (781) 250-0111
  • Fax: (781) 250-0115
  • Website

Description

Repligen Corporation was incorporated in 1981 in Delaware and is traded on the NASDAQ under the symbol RGEN. The Company is focused on the development of novel therapeutics for the treatment of diseases of the central nervous system and the immune system. Clinical development programs are currently being conducted in the areas of schizophrenia, bipolar disorder and multiple sclerosis. Repligen currently markets two products, Protein A and SecreFlo, the profits from which help to support our clinical development programs. The Company is located in Waltham Massachusetts and currently has approximately 40 employees.

Fact sheet

Company founded
1981
Number of employees
70
Annual revenue
$23000000

Company contacts

  • Walter C Herlihy
  • CEO

Products & services

investor relations

Similar companies nearby